Doxazosin mesylate
- Product NDC
- 71610-965
- 11-digit product format
- 716100965
- Labeler code
- 71610
- Product ID
- 71610-965_445e0469-117c-0ed5-e063-6394a90abe40
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- doxazosin mesylate
- Dosage form
- TABLET
- Route
- ORAL
- Labeler
- Aphena Pharma Solutions - Tennessee, LLC
- Application
- NDA019668
- Marketing category
- NDA AUTHORIZED GENERIC
- Marketing start
- 2025-09-24
- Substance
- DOXAZOSIN MESYLATE
- Active strength
- 4 mg/1
- Pharmacologic classes
- Adrenergic alpha-Antagonists [MoA], alpha-Adrenergic Blocker [EPC]
- NDC exclude flag
- No
- Listing certified through
- 2026-12-31
- Current FDA listing
- Yes
Additional Listing Data#
- Finished product
- Yes
- Brand name base
- Doxazosin mesylate
- Listing expiration
- 2026-12-31
Active Ingredients#
Ingredient, Strength table| Ingredient | Strength |
|---|
| DOXAZOSIN MESYLATE | 4 mg/1 |
Harmonized Identifiers#
Field, Values table| Field | Values |
|---|
| Unii | 86P6PQK0MU |
| Rxcui | 197627 |
DailyMed Product Concepts#
DailyMed Package Descriptions#
Package NDC, Product, Description table| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|
| 71610-965-53 | Doxazosin mesylate | 60 in 1 BOTTLE | TABLET | 60 | | 1 |
| 71610-965-60 | Doxazosin mesylate | 90 in 1 BOTTLE | TABLET | 90 | | 1 |
| 71610-965-70 | Doxazosin mesylate | 120 in 1 BOTTLE | TABLET | 120 | | 1 |
DailyMed RxNorm Mappings#
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Units | Marketing start | Sample | Exclude flag | Status |
|---|
| 71610-965-53 | 71610096553 | 60 TABLET in 1 BOTTLE (71610-965-53) | 60 tablet | 2025-11-21 | No | No | Historical |
| 71610-965-60 | 71610096560 | 90 TABLET in 1 BOTTLE (71610-965-60) | 90 tablet | 2025-11-21 | No | No | Historical |
| 71610-965-70 | 71610096570 | 120 TABLET in 1 BOTTLE (71610-965-70) | 120 tablet | 2025-11-21 | No | No | Historical |